Inhibition of cc chemokine receptor 10 ameliorates osteoarthritis via inhibition of the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin pathway

Yan Luo,Feng Zhou,Xiaojing Wang,Runwei Yang,Yi Li,Xiaochun Wu,Bin Ye
DOI: https://doi.org/10.1186/s13018-024-04642-x
IF: 2.6
2024-03-02
Journal of Orthopaedic Surgery and Research
Abstract:Osteoarthritis (OA) is a joint disease characterized by inflammation and progressive cartilage degradation. Chondrocyte apoptosis is the most common pathological feature of OA. Interleukin-1β (IL-1β), a major inflammatory cytokine that promotes cartilage degradation in OA, often stimulates primary human chondrocytes in vitro to establish an in vitro OA model. Moreover, IL-1β is involved in OA pathogenesis by stimulating the phosphoinositide-3-kinase (PI3K)/Akt and mitogen-activated protein kinases pathways. The G-protein-coupled receptor, cc chemokine receptor 10 (CCR10), plays a vital role in the occurrence and development of various malignant tumors. However, the mechanism underlying the role of CCR10 in the pathogenesis of OA remains unclear. We aimed to evaluate the protective effect of CCR10 on IL-1β-stimulated CHON-001 cells and elucidate the underlying mechanism.
orthopedics
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role and mechanism of CC chemokine receptor 10 (CCR10) in osteoarthritis (OA). Specifically, the study aims to evaluate the protective effect of CCR10 on interleukin - 1β (IL - 1β) - stimulated CHON - 001 cells (a chondrocyte cell line) and clarify its underlying mechanism. ### Research Background Osteoarthritis (OA) is a disease characterized by joint inflammation and progressive cartilage degeneration. Chondrocyte apoptosis is one of the most common pathological features of OA. IL - 1β, as a major pro - inflammatory cytokine, plays an important role in OA by stimulating cartilage degradation. In addition, IL - 1β is also involved in the pathogenesis of OA by activating the phosphatidylinositol - 3 - kinase (PI3K)/Akt and mitogen - activated protein kinase (MAPK) pathways. CCR10, as a G - protein - coupled receptor, plays an important role in the occurrence and development of various malignant tumors, but its role in the pathogenesis of OA is still unclear. ### Research Objectives The main objectives of this paper are: 1. **To evaluate the protective effect of CCR10 on IL - 1β - stimulated CHON - 001 cells**. 2. **To clarify the mechanism of action of CCR10 in IL - 1β - induced chondrocyte damage**, especially whether it reduces the inflammatory response and apoptosis by inhibiting the PI3K/Akt/mTOR signaling pathway. ### Method Overview - **Cell culture and OA model establishment**: CHON - 001 cells were used, and an in vitro OA model was constructed by adding 10 ng/mL of IL - 1β for 12 - hour stimulation. - **siRNA transfection**: CHON - 001 cells were transfected with control siRNA or CCR10 - siRNA for 24 hours, and then stimulated with IL - 1β for 12 hours. - **Detection indicators**: The expression levels of CCR10, cleaved caspase - 3, MMP - 3, MMP - 13, type II collagen, aggrecan, p - PI3K, PI3K, p - Akt, Akt, p - mTOR and mTOR were detected by quantitative reverse - transcription polymerase chain reaction (qRT - PCR) and Western blotting. Meanwhile, cell viability, cytotoxicity, apoptosis and the secretion of inflammatory cytokines (TNF - α, IL - 6, IL - 8) were evaluated by MTT assay, lactate dehydrogenase (LDH) determination, flow cytometry and enzyme - linked immunosorbent assay (ELISA), respectively. ### Main Findings - **CCR10 was significantly up - regulated in IL - 1β - stimulated CHON - 001 cells**, while CCR10 - siRNA treatment could significantly down - regulate CCR10 expression. - **CCR10 silencing significantly alleviated IL - 1β - induced chondrocyte damage**, manifested as increased cell viability, decreased LDH release, decreased apoptosis and decreased expression of cleaved caspase - 3. - **CCR10 silencing significantly inhibited IL - 1β - induced inflammatory response**, including decreased secretion of TNF - α, IL - 6 and IL - 8, decreased expression of MMP - 3 and MMP - 13, and increased expression of type II collagen and aggrecan. - **CCR10 silencing alleviated IL - 1β - induced chondrocyte damage by inhibiting the PI3K/Akt/mTOR pathway**, manifested as decreased expression of p - PI3K, p - Akt and p - mTOR. ### Conclusion This study shows that CCR10 inhibition can alleviate IL - 1β - induced chondrocyte damage by inhibiting the PI3K/Akt/mTOR pathway, suggesting that CCR10 may be a new target for the treatment of OA. ### Keywords CCR10, Osteoarthritis, PI3K/Akt/mTOR pathway